Samuel Kintz insider trades

Open-market stock purchases and sales by Samuel Kintz, PRESIDENT AND CEO at Enliven Therapeutics, Inc, from SEC Form 4 filings since Feb 23, 2023.

Recent trades

DateStockTradeValue
Nov 17, 2025ELVN Enliven Therapeutics, IncSold$273K
Oct 17, 2025ELVN Enliven Therapeutics, IncSold$267K

Companies traded

  • ELVN Enliven Therapeutics, Inc: 52 sales, last Nov 17, 2025

Get free alerts when Samuel Kintz files a new trade →